Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA methyltransferase 44 homolog (TRMT44) is a putative methyltransferase enzyme found in the cytoplasm that likely catalyzes methylation of uracil at the O(2) position in tRNA molecules, using S-adenosyl-L-methionine as the methyl donor. This protein is part of the TRM44 family and participates in tRNA modification processes important for proper RNA function. Mutations in TRMT44 have been associated in some studies with epilepsy, specifically partial epilepsy with pericentral spikes, and non-syndromic X-linked intellectual disability, though direct causality is not definitively established[2][3]. It is not generally considered a therapeutic target or receptor, and there are currently no drugs or drug mechanisms directly targeting this enzyme[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase 44 homolog (TRMT44).